EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY 4.0

The thrombopoietin receptor S264F mutant drives MPN with marrow fibrosis through a dual mechanism

Charlotte Lees, Emile Brandt, Emmanuel Dutranoix, Gabriel Levy, Bogdan I Iorga, Hosuk Ryou, Jens Rittscher, Daniel Royston iD, Stefan N Constantinescu, Adam J Mead iD

HemaSphere · 2026-10 · 10 (10)

DOI: 10.1002/hem3.70437 ↗

Kurz gefasst

Leserbrief in der Zeitschrift HemaSphere, online erschienen am 07.10.2026. Verfasst von Charlotte Lees und 9 weiteren Autor:innen. Beteiligte Einrichtung: MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine and National Institute of Health Res…. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Ludwig Institute for Cancer Research.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine and National Institute of Health Research (NIHR), Oxford Biomedical Research Centre University of Oxford O…
  • de Duve Institute Université Catholique de Louvain Brussels Belgium.
  • Ludwig Institute for Cancer Research Brussels Belgium.
  • Institut de Chimie des Substances Naturelles Université Paris-Saclay, CNRS Gif-sur-Yvette France.
  • Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine University of Oxford Oxford United Kingdom.
  • Institute of Biomedical Engineering (IBME), Department of Engineering Science University of Oxford Oxford United Kingdom.

ORCID-Profile: Daniel Royston, Adam J Mead

Förderung

  • Medical Research Council
  • Ludwig Institute for Cancer Research

Zitieren

APA

Lees, C., Brandt, E., Dutranoix, E., Levy, G., Iorga, B. I., Ryou, H., Rittscher, J., Royston, D., Constantinescu, S. N., & Mead, A. J. (2026). The thrombopoietin receptor S264F mutant drives MPN with marrow fibrosis through a dual mechanism. HemaSphere, 10(10). https://doi.org/10.1002/hem3.70437

Vancouver

Lees C, Brandt E, Dutranoix E, Levy G, Iorga BI, Ryou H, et al. The thrombopoietin receptor S264F mutant drives MPN with marrow fibrosis through a dual mechanism. HemaSphere. 2026;10(10). doi:10.1002/hem3.70437

BibTeX
@article{Lees2026,
  author = {Lees, Charlotte and Brandt, Emile and Dutranoix, Emmanuel and Levy, Gabriel and Iorga, Bogdan I and Ryou, Hosuk and Rittscher, Jens and Royston, Daniel and Constantinescu, Stefan N and Mead, Adam J},
  title = {The thrombopoietin receptor S264F mutant drives MPN with marrow fibrosis through a dual mechanism},
  journal = {HemaSphere},
  year = {2026},
  volume = {10},
  number = {10},
  doi = {10.1002/hem3.70437}
}
Kostenlos starten →